Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Global Kratom Coalition Highlights New Medical Review on Natural vs. Synthetic Kratom Products
GlobeNewswire, Inc.
Washington, D.C., USA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Peer-reviewed Missouri Medicine article by Drs. Mark S. Gold and Nicole M. Avena is now indexed in PubMed The Global Kratom Coalition today highlights a newly published peer-reviewed...
Five Reputable IGBT Module Distributors in China 2026: Empowering Power Electronics Industry
EIN Presswire
Connecting Global Buyers with Reliable IGBT Module Sourcing, Distribution, and Power Semiconductor Solutions CALIFORNIA, CA, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- KUNSHAN, China, Sept. 30, 2026 — China's IGBT module supply...
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR. A conference call will be held on September 30, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Strong momentum and expanding global access position AGAMREE® for...
SORBA.ai and KOPAR Announce Strategic Channel Partnership to Accelerate Industrial AI Across Mexico
EIN Presswire
KOPAR and SORBA.ai combine industrial automation and no-code AI to deliver predictive analytics, anomaly detection, and condition monitoring.
Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
GlobeNewswire, Inc.
Press release – No. 18 / 2026 Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology Treatment with petrelintide was...
ANH Petitions FDA to Restore Safe Harbor for Homeopathic Medicines
EIN Presswire
Citizen Petition calls for reinstatement of CPG 400.400, formal rulemaking, and a science-based “traffic-light” enforcement framework ALEXANDRIA, VA, UNITED STATES, October 1, 2026 /EINPresswire.com/ -- The Alliance for Natural Health USA...
Paperguide Launches AI-Assisted Systematic Review Software With Built-In Dual Review
EIN Presswire
AI-assisted screening meets independent dual review, with PRISMA reporting and a full audit trail for HEOR, pharma, and medical device teams.
TOWER and Druk Holding & Investments Partner to Build Bhutan’s Generational Health Ecosystem
EIN Presswire
A sovereign-scale effort to make Generational Health national infrastructure—linking science, capital, and systems for health that compounds across generations.
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
GlobeNewswire, Inc.
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced...
Inseego Names Nick Lambourne Chief Technology Officer to Lead Global Engineering Organization
GlobeNewswire, Inc.
SAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG), a global leader in wireless broadband connectivity, today announced that Nick Lambourne has joined the company as Chief Technology Officer.
Nox Peptides Introduces Educational Resources and Research Tools for Peptide Science
GlobeNewswire, Inc.
TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has introduced a collection of educational resources and practical research tools designed to help readers and researchers better understand peptide science and common laboratory concepts...
CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech
GlobeNewswire, Inc.
Dubai, United Arab Emirates, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aptadir raises €40 million in Italy’s largest biotech seed round and one of the largest in Europe Financing will advance a novel class of RNA inhibitor-based therapeutics, including...
Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight The software as a medical device market is experiencing strong growth, driven by the...
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
GlobeNewswire, Inc.
- New Phase 1 data highlight flexibility of injection site for ribupatide injection - Four additional oral presentations from Hengrui Pharma add to the clinical evidence behind Kailera's pipeline WALTHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) --...
Aro Biotherapeutics Appoints Biotechnology Executive Brett Blackman, Ph.D., to its Board of Directors
GlobeNewswire, Inc.
PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aro Biotherapeutics, a clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for the treatment of diseases with high unmet medical need, today announced...
Dr. Ricardo Schwarcz Announces New Scholarship for Healthcare Sciences to Support Future Medical Leaders Across the USA
GlobeNewswire, Inc.
HARLINGEN, Texas, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The Dr. Ricardo Schwarcz Scholarship for Healthcare Sciences announces its opening for applications, offering a unique opportunity for undergraduate students nationwide who demonstrate a...
Dr. Matt Kaeberlein Joins The Cat Health Company’s Scientific Advisory Board
EIN Presswire
Dr. Kaeberlein, a founding figure in the science of companion-animal aging, brings decades of expertise to The Cat Health Company’s work on aging.
TekniPlex Healthcare to Showcase Wearable Drug Delivery, Ophthalmic Innovations, and Pharmaceutical Protection at CPHI Milan 2026
GlobeNewswire, Inc.
Wayne, PA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The materials that protect and deliver medicines are changing.
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
GlobeNewswire, Inc.
SAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced data published in the Proceedings of the National...
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire, Inc.
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule.
Sign up for:
Technology News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.